HK1056361A1 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
HK1056361A1
HK1056361A1 HK03108712A HK03108712A HK1056361A1 HK 1056361 A1 HK1056361 A1 HK 1056361A1 HK 03108712 A HK03108712 A HK 03108712A HK 03108712 A HK03108712 A HK 03108712A HK 1056361 A1 HK1056361 A1 HK 1056361A1
Authority
HK
Hong Kong
Prior art keywords
novel compounds
substituted
triazolo
pyrimidines
medicaments
Prior art date
Application number
HK03108712A
Other languages
English (en)
Inventor
Simon Guile
Barrie Martin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1056361A1 publication Critical patent/HK1056361A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
HK03108712A 2000-11-09 2003-11-28 Novel compounds HK1056361A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0004098A SE0004098D0 (sv) 2000-11-09 2000-11-09 Novel compounds
PCT/SE2001/002472 WO2002038571A1 (en) 2000-11-09 2001-11-07 Novel compounds

Publications (1)

Publication Number Publication Date
HK1056361A1 true HK1056361A1 (en) 2004-02-13

Family

ID=20281755

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108712A HK1056361A1 (en) 2000-11-09 2003-11-28 Novel compounds

Country Status (10)

Country Link
US (2) US6844348B2 (xx)
EP (1) EP1335918B1 (xx)
JP (1) JP4190282B2 (xx)
AT (1) ATE339420T1 (xx)
AU (1) AU2002212941A1 (xx)
DE (1) DE60123103T2 (xx)
ES (1) ES2271083T3 (xx)
HK (1) HK1056361A1 (xx)
SE (1) SE0004098D0 (xx)
WO (1) WO2002038571A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004107A1 (en) * 2004-07-02 2006-01-05 Masanori Ojima Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same
DE102008002471A1 (de) * 2008-06-17 2009-12-24 Biotronik Vi Patent Ag Stent mit einer Beschichtung oder einem Grundkörper, der ein Lithiumsalz enthält, und Verwendung von Lithiumsalzen zur Restenoseprophylaxe
CN102653539B (zh) * 2011-03-01 2014-09-17 秦引林 一种抗血小板聚集化合物及其药物组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW530058B (en) 1997-07-22 2003-05-01 Astra Pharma Prod Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation

Also Published As

Publication number Publication date
SE0004098D0 (sv) 2000-11-09
DE60123103T2 (de) 2007-03-15
ES2271083T3 (es) 2007-04-16
US20040029899A1 (en) 2004-02-12
US20050143399A1 (en) 2005-06-30
AU2002212941A1 (en) 2002-05-21
EP1335918B1 (en) 2006-09-13
JP2004513173A (ja) 2004-04-30
WO2002038571A1 (en) 2002-05-16
EP1335918A1 (en) 2003-08-20
US7345047B2 (en) 2008-03-18
US6844348B2 (en) 2005-01-18
DE60123103D1 (de) 2006-10-26
JP4190282B2 (ja) 2008-12-03
ATE339420T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
MY121867A (en) Novel triazolo(4,5-d)pyrimidine compounds.
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
ID24837A (id) Senyawa triazolo [4,5-d] pirimidina, penggunaan, komposisi dan proses pembuatannya
WO2003095455A3 (en) Substituted pyrazolopyrimidines
MY140674A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
WO2002048147A3 (en) Pyrazolopyridines
AU2002341920A1 (en) Chemical compounds
WO2004074244A3 (en) Pyrimidine compounds
GB0111186D0 (en) Novel compounds
TR200000152T2 (tr) Yeni bileşikler.
WO2002048148A3 (en) Pyrazolopyridine derivatives
WO2001098275A3 (en) 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
HUP0303486A3 (en) Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anti-arrythmic compounds agents
HK1056361A1 (en) Novel compounds
HK1056362A1 (en) Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents
HUP0400443A3 (en) Pyrazolo[1,2-a][1,2,4]triazole compounds useful as anti-inflammatory agents and pharmaceutical compositions containing them
SI0996621T1 (en) TRIAZOLO(4,5-d)PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101107